JP2016532632A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016532632A5 JP2016532632A5 JP2016515425A JP2016515425A JP2016532632A5 JP 2016532632 A5 JP2016532632 A5 JP 2016532632A5 JP 2016515425 A JP2016515425 A JP 2016515425A JP 2016515425 A JP2016515425 A JP 2016515425A JP 2016532632 A5 JP2016532632 A5 JP 2016532632A5
- Authority
- JP
- Japan
- Prior art keywords
- fibrosis
- pharmaceutically acceptable
- pharmaceutically
- stereoisomers
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 9
- 150000003839 salts Chemical class 0.000 claims 8
- 206010016654 Fibrosis Diseases 0.000 claims 6
- 230000004761 fibrosis Effects 0.000 claims 6
- 239000003795 chemical substances by application Substances 0.000 claims 5
- 239000008194 pharmaceutical composition Substances 0.000 claims 5
- 238000011282 treatment Methods 0.000 claims 4
- 206010020772 Hypertension Diseases 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 206010028594 Myocardial fibrosis Diseases 0.000 claims 2
- 239000003814 drug Substances 0.000 claims 2
- 201000002793 renal fibrosis Diseases 0.000 claims 2
- 229940124597 therapeutic agent Drugs 0.000 claims 2
- 206010065918 Prehypertension Diseases 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 201000011461 pre-eclampsia Diseases 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2013903573 | 2013-09-17 | ||
| AU2013903573A AU2013903573A0 (en) | 2013-09-17 | Compositions for the treatment of hypertension and/or fibrosis | |
| PCT/AU2014/000923 WO2015039173A1 (en) | 2013-09-17 | 2014-09-17 | Compositions for the treatment of hypertension and/or fibrosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2016532632A JP2016532632A (ja) | 2016-10-20 |
| JP2016532632A5 true JP2016532632A5 (enExample) | 2016-12-08 |
| JP6122548B2 JP6122548B2 (ja) | 2017-04-26 |
Family
ID=52687998
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2016515425A Active JP6122548B2 (ja) | 2013-09-17 | 2014-09-17 | 高血圧及び／又は線維症の処置用組成物 |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US9458093B2 (enExample) |
| EP (1) | EP3046901B1 (enExample) |
| JP (1) | JP6122548B2 (enExample) |
| KR (1) | KR101736416B1 (enExample) |
| CN (1) | CN105683152B (enExample) |
| AP (1) | AP2016009079A0 (enExample) |
| AU (1) | AU2014324078B2 (enExample) |
| BR (1) | BR112016005601B1 (enExample) |
| CA (1) | CA2924356C (enExample) |
| DK (1) | DK3046901T3 (enExample) |
| ES (1) | ES2655455T3 (enExample) |
| IL (1) | IL244621A (enExample) |
| MX (1) | MX368865B (enExample) |
| MY (1) | MY172557A (enExample) |
| NO (1) | NO3046901T3 (enExample) |
| NZ (1) | NZ717927A (enExample) |
| PH (1) | PH12016500497B1 (enExample) |
| PL (1) | PL3046901T3 (enExample) |
| RU (1) | RU2635564C2 (enExample) |
| SG (1) | SG11201601642WA (enExample) |
| UA (1) | UA118111C2 (enExample) |
| WO (1) | WO2015039173A1 (enExample) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3284981B2 (ja) | 1998-11-02 | 2002-05-27 | 株式会社デンソー | 車両用交流発電機およびそのステータの製造方法 |
| US9956166B2 (en) | 2013-09-18 | 2018-05-01 | Sorrento Therapeutics, Inc. | Methods for administration and methods for treating cardiovascular diseases with resiniferatoxin |
| JP6734294B2 (ja) * | 2015-03-18 | 2020-08-05 | ヴェクタス バイオシステムズ リミテッド | 線維症及び線維症に関連する状態の処置のための組成物 |
| SG11201707555RA (en) * | 2015-03-18 | 2017-10-30 | Vectus Biosystems Ltd | Compositions for the treatment of kidney and/or liver disease |
| BR112018005619B1 (pt) | 2015-09-22 | 2022-11-29 | Vectus Biosystems Limited | Método para produzir um composto, composto e uso de um composto |
| IL298314B2 (en) * | 2016-04-13 | 2025-04-01 | Univ Nebraska | Methods of administration and methods of treating cardiovascular diseases with resiniparatoxin |
| UA124468C2 (uk) * | 2016-07-28 | 2021-09-22 | Вектус Байосистемз Лімітед | Композиції для лікування легеневого фіброзу |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2694288B1 (fr) * | 1992-06-30 | 1994-09-09 | Rhone Poulenc Agrochimie | Phenylbenzamides fongicides et procédés pour les préparer. |
| DK1768689T3 (en) * | 2004-06-11 | 2014-12-01 | Vectus Biosystems Ltd | Compositions and methods for treating cardiovascular disease |
| WO2007065226A1 (en) * | 2005-12-09 | 2007-06-14 | Vectus Biosystems Limited | Vip fragments and methods of use |
| US20120088737A2 (en) * | 2009-10-02 | 2012-04-12 | Ajinomoto Co., Inc | Novel acyl guanidine derivatives |
| SG11201601641VA (en) * | 2013-09-17 | 2016-04-28 | Vectus Biosystems Ltd | Compositions for the treatment of hypertension and/or fibrosis |
-
2014
- 2014-09-17 CN CN201480050979.1A patent/CN105683152B/zh active Active
- 2014-09-17 ES ES14845373.1T patent/ES2655455T3/es active Active
- 2014-09-17 UA UAA201602267A patent/UA118111C2/uk unknown
- 2014-09-17 US US15/022,278 patent/US9458093B2/en active Active
- 2014-09-17 DK DK14845373.1T patent/DK3046901T3/en active
- 2014-09-17 AU AU2014324078A patent/AU2014324078B2/en active Active
- 2014-09-17 MX MX2016003371A patent/MX368865B/es active IP Right Grant
- 2014-09-17 NZ NZ717927A patent/NZ717927A/en unknown
- 2014-09-17 JP JP2016515425A patent/JP6122548B2/ja active Active
- 2014-09-17 AP AP2016009079A patent/AP2016009079A0/xx unknown
- 2014-09-17 NO NO14845373A patent/NO3046901T3/no unknown
- 2014-09-17 WO PCT/AU2014/000923 patent/WO2015039173A1/en not_active Ceased
- 2014-09-17 SG SG11201601642WA patent/SG11201601642WA/en unknown
- 2014-09-17 BR BR112016005601-9A patent/BR112016005601B1/pt active IP Right Grant
- 2014-09-17 RU RU2016112257A patent/RU2635564C2/ru active
- 2014-09-17 EP EP14845373.1A patent/EP3046901B1/en active Active
- 2014-09-17 PL PL14845373T patent/PL3046901T3/pl unknown
- 2014-09-17 MY MYPI2016000482A patent/MY172557A/en unknown
- 2014-09-17 CA CA2924356A patent/CA2924356C/en active Active
- 2014-09-17 KR KR1020167008664A patent/KR101736416B1/ko active Active
-
2016
- 2016-03-14 PH PH12016500497A patent/PH12016500497B1/en unknown
- 2016-03-16 IL IL244621A patent/IL244621A/en active IP Right Grant
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014507446A5 (enExample) | ||
| JP2016532632A5 (enExample) | ||
| JP2017537066A5 (enExample) | ||
| JP2016518337A5 (enExample) | ||
| JP2015078230A5 (enExample) | ||
| JP2018521020A5 (enExample) | ||
| JP2012107057A5 (enExample) | ||
| JP2013014622A5 (enExample) | ||
| JP2013032389A5 (enExample) | ||
| JP2014221779A5 (enExample) | ||
| JP2017186358A5 (enExample) | ||
| JP2011105738A5 (enExample) | ||
| JP2014515013A5 (enExample) | ||
| EP4643945A3 (en) | Neuroactive steroids and methods of use thereof | |
| JP2013532130A5 (enExample) | ||
| HK1244708A1 (zh) | 作爲fxr/tgr5激动剂的胆汁酸类似物及其使用方法 | |
| JP2013532687A5 (enExample) | ||
| JP2011518833A5 (enExample) | ||
| JP2017514910A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2019516735A5 (enExample) | ||
| EP4316591A3 (en) | Oxysterols and methods of use thereof | |
| MX394588B (es) | Composición farmacéutica. | |
| JP2016510326A5 (enExample) | ||
| JP2015516419A5 (enExample) |